ARMONAIR DIGIHALER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Armonair Digihaler, and when can generic versions of Armonair Digihaler launch?
Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. There are twenty-four patents protecting this drug.
This drug has four hundred and fifty patent family members in thirty-four countries.
The generic ingredient in ARMONAIR DIGIHALER is fluticasone propionate. There are twenty-nine drug master file entries for this compound. Sixty-seven suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Armonair Digihaler
A generic version of ARMONAIR DIGIHALER was approved as fluticasone propionate by FOUGERA PHARMS on May 14th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ARMONAIR DIGIHALER?
- What are the global sales for ARMONAIR DIGIHALER?
- What is Average Wholesale Price for ARMONAIR DIGIHALER?
Summary for ARMONAIR DIGIHALER
International Patents: | 450 |
US Patents: | 24 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 86 |
Patent Applications: | 5,455 |
Drug Prices: | Drug price information for ARMONAIR DIGIHALER |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ARMONAIR DIGIHALER |
What excipients (inactive ingredients) are in ARMONAIR DIGIHALER? | ARMONAIR DIGIHALER excipients list |
DailyMed Link: | ARMONAIR DIGIHALER at DailyMed |


Pharmacology for ARMONAIR DIGIHALER
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for ARMONAIR DIGIHALER
ARMONAIR DIGIHALER is protected by twenty-five US patents and two FDA Regulatory Exclusivities.
Expired US Patents for ARMONAIR DIGIHALER
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-004 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-004 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-006 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-006 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-005 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
Teva Pharm | ARMONAIR DIGIHALER | fluticasone propionate | POWDER;INHALATION | 208798-006 | Feb 20, 2020 | ⤷ Try for Free | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ARMONAIR DIGIHALER
See the table below for patents covering ARMONAIR DIGIHALER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2988391 | ⤷ Try for Free | |
European Patent Office | 2436414 | Compteur de doses pour inhalateurs et inhalateur (Dose counter for inhalers and inhaler) | ⤷ Try for Free |
Eurasian Patent Organization | 201300230 | СПОСОБ СЕРИЙНОГО ПРОИЗВОДСТВА ИНКРЕМЕНТАЛЬНЫХ СЧЕТЧИКОВ ДОЗ ДЛЯ ИНГАЛЯТОРОВ И СПОСОБ ИЗГОТОВЛЕНИЯ СЕРИИ ИНГАЛЯТОРОВ | ⤷ Try for Free |
Japan | 2020501855 | 組み込まれた電子モジュールを有する吸入デバイス | ⤷ Try for Free |
Denmark | 2514462 | ⤷ Try for Free | |
Denmark | 3002022 | ⤷ Try for Free | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ARMONAIR DIGIHALER
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2506844 | SPC/GB18/020 | United Kingdom | ⤷ Try for Free | PRODUCT NAME: A PHARMACEUTICAL COMBINATION PRODUCT COMPRISING A PHARMACEUTICALLY ACCEPTABLE SALT OF UMECLIDINIUM (E.G. UMECLIDINIUM BROMIDE), VILANTEROL OR A PHARMACEUTICALLY ACCETPABLE SALT THEREOF (E.G. VILANTEROL TRIFENATATE), AND FLUTICASONE FUROATE; REGISTERED: UK EU/1/17/1236/001(NI) 20171117; UK EU/1/17/1236/002(NI) 20171117; UK EU/1/17/1236/003(NI) 20171117; UK PLGB 19494/0287 20171117 |
1519731 | 92269 | Luxembourg | ⤷ Try for Free | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
2506844 | LUC00077 | Luxembourg | ⤷ Try for Free | PRODUCT NAME: PRODUIT DE COMBINAISON PHARMACEUTIQUE COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (PAR EXEMPLE LE BROMURE D'UMECLIDINIUM), LE VILANTEROL OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE (PAR EXEMPLE LE TRIFENATATE DE VILANTEROL) ET LE FUROATE DE FLUTICASONE; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
1305329 | 08C0014 | France | ⤷ Try for Free | PRODUCT NAME: FLUTICASONE FUROATE; REGISTRATION NO/DATE: EU/1/07/434/001 20080111 |
2506844 | 2018C/022 | Belgium | ⤷ Try for Free | PRODUCT NAME: EEN FARMACEUTISCH COMBINATIEPRODUCT DAT EEN FARMACEUTISCH AANVAARDBAAR ZOUT VAN UMECLIDINIUM (BV. UMECLIDINIUMBROMIDE), VILANTEROL OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN (BV. VILANTEROLTRIFENATAAT) EN FLUTICASONEFUROAAT OMVAT; AUTHORISATION NUMBER AND DATE: EU/1/17/1236 20171117 |
1519731 | 132013902182575 | Italy | ⤷ Try for Free | PRODUCT NAME: AZELASTINA CLORIDRATO/FLUTICASONE PROPIONATO(DYMISTA); AUTHORISATION NUMBER(S) AND DATE(S): 2011/07125-REG, 20111024;041808015/M-027/M-039/M-041/M, 20130527 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for ArmonAir Digihaler
More… ↓